Overall (n = 53) A-paced (n = 27) V-paced (n = 26) p
Sex (% male) 74% (39/53) 74% (20/27) 73% (19/26) 1
Age (yrs) 63 ± 12 64 ± 10 62 ± 14 0.92
BMI (kg/m2) 30.7 ± 6.5 29.3 ± 4.6 32.1 ± 7.8 0.12
LVEF (%) 55 ± 12 57 ± 12 53 ± 13 0.11
LA Diameter (cm) 4.6 ± 0.7 4.4 ± 0.8 4.9 ± 0.6 0.02
LA Volume Index (mL/m2) 37 ± 13 33 ± 8 41 ± 15 0.14
Years Since AF Diagnosis 3.4 ± 4.5 2.5 ± 4.2 4.4 ± 4.7 0.02
CHA2DS2-VASc 2.1 ± 1.7 2.0 ± 1.6 2.2 ± 1.7 0.78
HTN 62% (33/53) 59% (16/27) 65% (17/26) 0.78
DM 15% (8/53) 19% (5/27) 12% (3/26) 0.7
CHF 21% (11/53) 22% (6/27) 19% (5/26) 1
CVA 6% (3/53) 4% (1/27) 8% (2/26) 0.61
Vascular Disease 4% (2/53) 7% (2/27) 0% (0/26) 0.49
OSA 36% (19/53) 37% (10/27) 35% (9/26) 1
Post-Ablation Medications
Anti-arrhythmic 87% (46/53) 81% (22/27) 92% (24/26) 0.42
BB or CCB 85% (45/53) 78% (21/27) 92% (24/26) 0.25
Post-Ablation Monitoring
ILR, PPM, or ICD 11% (6/53) 11% (3/27) 12% (3/26) 1
Number of Monitors 2.3 ± 1.1 2.4 ± 1.0 2.1 ± 1.2 0.41